Last updated: Nov 20, 2026, 12:00 AM

BridgeBio Pharma Inc Exchange (NASDAQ, USD)

BBIO

78.01
+1.21 (+1.58%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
16.61%
3 year return (CAGR)
41.53%
5 year return (CAGR)
9.61%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
15.20B
Price/Sales
21.97
Ent value
17.48B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-0.56%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open76.45
Daily high78.25
Daily low75.99
Daily Volume3.55M
All-time high90.17
1y analyst estimate106.85
Beta0.94
EPS (TTM)-3.56
Dividend per share0.00
Ex-div date-
Next earnings date19 Feb 2026

Ready to capitalize on BridgeBio Pharma Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
BBIOS&P500
Current price drop from All-time high-13.49%-6.28%
Highest price drop-92.80%-56.47%
Date of highest drop11 May 20229 Mar 2009
Avg drop from high-43.92%-10.64%
Avg time to new high37 days12 days
Max time to new high1211 days1805 days